Siemens ADVIA Centaur DHEAS Assay Recalled for Temperature Sensitivity
Siemens Healthcare is recalling ADVIA Centaur DHEAS assays because room temperature changes can alter test results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential inaccuracies in test results due to environmental factors rather than direct physical injury or contamination.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the ADVIA Centaur DHEA-504 (DHEAS) 50 Test assay, catalog number 06489701. This in vitro diagnostic immunoassay is used to measure dehydroepiandrosterone sulfate (DHEAS) levels in human serum and plasma on ADVIA Centaur and ADVIA Centaur XP systems.
The recall is due to the assay's sensitivity to room temperature. The operating range for the ADVIA Centaur systems is 18°C to 30°C (64.4°F to 86.0°F). Changes in room temperature may increase or decrease assay results, depending on the specific assay and system used.
The recall involves 12,976 units distributed worldwide, including the United States and numerous international locations. All lot codes are affected. Users should contact Siemens Healthcare Diagnostics, Inc. for further instructions regarding the recall.
The recalled product
- Product
- Siemens Healthcare ADVIA Centaur DHEA-504 (DHEAS) 50 Test 06489701 The ADVIA Centaur DHEAS assay is an in vitro diagnostic immunoassay for the quantitative determination of dehydroepiandrosterone sulfate (DHEAS) in human serum and plasma using the ADVIA Centaur and ADVIA Cent
- Manufacturer
- Siemens Healthcare Diagnostics, Inc
- Hazard
- Affected units
- 12,976
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lot codes
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Siemens Healthcare Diagnostics, Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
FDA (Devices) · 2026-05-06